Advanced search
Start date
Betweenand

Probability of pharmacodynamic exposure of antimicrobial regimens commonly prescribed in the city of São Paulo against Streptococcus pneumoniae of the EUREQA project

Grant number: 09/13825-2
Support type:Research Grants - Young Investigators Grants
Duration: February 01, 2010 - January 31, 2012
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal Investigator:Carlos Roberto Veiga Kiffer
Grantee:Carlos Roberto Veiga Kiffer
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Associated scholarship(s):10/02630-3 - Probability of pharmacodynamic exposure of antimicrobial regimens commonly prescribed in the city of São Paulo against Streptococcus pneumoniae of the EUREQA project, BP.JP

Abstract

In the context of resistance, the present project will allow us to understand the correlation among empiric treatment commonly used for respiratory infections and susceptibility profile of Streptococcus pneumoniae in the same environment, through a pharmacodynamic simulation model which uses bacterial eradication targets to each treatment prescribed. Then, it will be possible to infere about which regimens are more prone to resistance induction. This project is linked to the EUREQA Project (FAPESP 06/53922-9). EUREQA has its focus in the correlation of antimicrobial use and resistance emergence; however it does not explore the pharmacodynamic relations among antimicrobials and the infectious processes to which they are prescribed. Therefore, hopefully there will be an increment in the understanding of the use-resistance phenomenon through the present project. (AU)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
KIFFER, CARLOS R. V.; PIGNATARI, ANTONIO C. C. Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens. BMC INFECTIOUS DISEASES, v. 11, OCT 25 2011. Web of Science Citations: 7.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.